Intuitive Surgical Expands Stock Repurchase Program to $4B

Intuitive Surgical ( (ISRG) ) just unveiled an update.

On May 1, 2025, Intuitive Surgical‘s stockholders approved several proposals at the annual meeting, including the amendment and restatement of the 2010 Incentive Award Plan, which increases the number of shares reserved for issuance and extends the plan’s term. Additionally, the company announced an increase in its stock repurchase program to $4.0 billion, indicating a strategic move to enhance shareholder value and manage its capital structure.

Spark’s Take on ISRG Stock

According to Spark, TipRanks’ AI Analyst, ISRG is a Outperform.

Intuitive Surgical’s overall stock score reflects its robust financial performance, characterized by strong profitability, growth, and liquidity. Positive earnings call guidance further enhances its outlook, despite high valuation concerns and moderate technical indicators. Challenges such as tariff impacts and international market stresses are notable but are balanced by the company’s strategic strengths and innovation initiatives.

To see Spark’s full report on ISRG stock, click here.

More about Intuitive Surgical

Intuitive Surgical, Inc. operates in the medical technology industry, focusing on the development and manufacturing of robotic-assisted surgical systems. The company’s primary product is the da Vinci Surgical System, which is designed to facilitate complex surgery using a minimally invasive approach.

YTD Price Performance: 1.03%

Average Trading Volume: 2,280,483

Technical Sentiment Signal: Sell

Current Market Cap: $189.8B

See more insights into ISRG stock on TipRanks’ Stock Analysis page.